Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1386]
News [2583]
Articles [24]
Editorials [0]
Conferences [149]
elearning [15]
Discussion: Additional treatment options impact first-line treatment of mRCC
Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
Discussion: Additional treatment options impact first-line treatment of mRCC ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014
Additional treatment options impact first-line treatment of mRCC: Yes
Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Additional treatment options impact first-line treatment of mRCC: Yes ( Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
23 Sep 2014
What have we learned? Expert perspectives
Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
What have we learned? Expert perspectives ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014
From clinical trial to clinical practice: Evidence from the real world
Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid...
From clinical trial to clinical practice: Evidence from the real world ( Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madrid, Spain )
23 Sep 2014
The evolving treatment landscape for HER2-positive metastatic breast cancer
Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium
The evolving treatment landscape for HER2-positive metastatic breast cancer ( Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium )
18 Sep 2014
Navigating current treatment options for HER2-positive MBC: Patient journey 1
Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria
Navigating current treatment options for HER2-positive MBC: Patient journey 1 ( Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria )
18 Sep 2014
ecancermedicalscience editor's choice for September 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for September 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Sep 2014
Benefits of investing in skin cancer prevention
Craig Sinclair - Cancer Council Victoria, Victoria, Australia
Benefits of investing in skin cancer prevention ( Craig Sinclair - Cancer Council Victoria, Victoria, Australia )
11 Sep 2014
Preventing skin cancer worldwide and the impact of different regulatory and...
Prof Darrell Rigel - New York University Medical Center, New York, USA
Preventing skin cancer worldwide and the impact of different regulatory and economic priorities ( Prof Darrell Rigel - New York University Medical Center, New York, USA )
11 Sep 2014
The Euro Melanoma campaign and the importance of communication, education, and...
Prof Veronique del Marmol - Chair of Euromelanoma Europe, Brussels, Belgium
The Euro Melanoma campaign and the importance of communication, education, and understanding of skin cancer ( Prof Veronique del Marmol - Chair of Euromelanoma Europe, Brussels, Belgium )
11 Sep 2014
Overview of skin cancer treatments, past, present and future
Prof John Hawk - President of the World Congress on Cancers of the Skin 2014
Overview of skin cancer treatments, past, present and future ( Prof John Hawk - President of the World Congress on Cancers of the Skin 2014 )
11 Sep 2014
Skin cancer across the world and ways of preventing risk
Prof Adele Green - Deputy Director, Queensland Institute of Medical Research...
Skin cancer across the world and ways of preventing risk ( Prof Adele Green - Deputy Director, Queensland Institute of Medical Research, Brisbane, Australia )
11 Sep 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation